Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4587414
Max Phase: Preclinical
Molecular Formula: C12H16N2O
Molecular Weight: 204.27
Molecule Type: Unknown
Associated Items:
ID: ALA4587414
Max Phase: Preclinical
Molecular Formula: C12H16N2O
Molecular Weight: 204.27
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)(C)c1ccc2oc(CN)nc2c1
Standard InChI: InChI=1S/C12H16N2O/c1-12(2,3)8-4-5-10-9(6-8)14-11(7-13)15-10/h4-6H,7,13H2,1-3H3
Standard InChI Key: SIHHRUINFFFVPO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 204.27 | Molecular Weight (Monoisotopic): 204.1263 | AlogP: 2.58 | #Rotatable Bonds: 1 |
Polar Surface Area: 52.05 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.08 | CX LogP: 2.06 | CX LogD: 1.89 |
Aromatic Rings: 2 | Heavy Atoms: 15 | QED Weighted: 0.78 | Np Likeness Score: -1.20 |
1. (2018) Lysyl oxidase-like 2 inhibitors and uses thereof, |
Source(1):